| Dr Kalyan C Latchamsetty, MD | |
|
2020 Ogden Ave Ste 335, Aurora, IL 60504 | |
| (630) 692-5700 | |
| (630) 692-5750 |
| Full Name | Dr Kalyan C Latchamsetty |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 25 Years |
| Location | 2020 Ogden Ave Ste 335, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699724138 | NPI | - | NPPES |
| 036113643 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 036113643 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Copley Memorial Hospital | Aurora, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush-copley Medical Group Nfp | 7618864877 | 108 |
News Archive
Scientists have calculated more precise measurements of heritability-the influence of underlying genes-in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
A Cedars-Sinai team of researchers led by principal investigator Dan Gazit, PhD, DMD, has been awarded a $5.18 million grant from California's stem cell research agency to advance stem cell technologies in segmental bone defects, a complex medical problem caused by large portions of bone tissue loss.
"Boosting women's access to reproductive health care could significantly reduce both the number of unsafe abortions and the high cost of post-abortion medical care in Uganda, experts say," IRIN reports.
› Verified 7 days ago
| Entity Name | Rush-copley Medical Group Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
Scientists have calculated more precise measurements of heritability-the influence of underlying genes-in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
A Cedars-Sinai team of researchers led by principal investigator Dan Gazit, PhD, DMD, has been awarded a $5.18 million grant from California's stem cell research agency to advance stem cell technologies in segmental bone defects, a complex medical problem caused by large portions of bone tissue loss.
"Boosting women's access to reproductive health care could significantly reduce both the number of unsafe abortions and the high cost of post-abortion medical care in Uganda, experts say," IRIN reports.
› Verified 7 days ago
| Entity Name | Copley Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619466034 PECOS PAC ID: 4587656921 Enrollment ID: O20180530001537 |
News Archive
Scientists have calculated more precise measurements of heritability-the influence of underlying genes-in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
A Cedars-Sinai team of researchers led by principal investigator Dan Gazit, PhD, DMD, has been awarded a $5.18 million grant from California's stem cell research agency to advance stem cell technologies in segmental bone defects, a complex medical problem caused by large portions of bone tissue loss.
"Boosting women's access to reproductive health care could significantly reduce both the number of unsafe abortions and the high cost of post-abortion medical care in Uganda, experts say," IRIN reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kalyan C Latchamsetty, MD 2020 Ogden Ave Ste 335, Aurora, IL 60504-5897 Ph: (630) 692-5700 | Dr Kalyan C Latchamsetty, MD 2020 Ogden Ave Ste 335, Aurora, IL 60504 Ph: (630) 692-5700 |
News Archive
Scientists have calculated more precise measurements of heritability-the influence of underlying genes-in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
A Cedars-Sinai team of researchers led by principal investigator Dan Gazit, PhD, DMD, has been awarded a $5.18 million grant from California's stem cell research agency to advance stem cell technologies in segmental bone defects, a complex medical problem caused by large portions of bone tissue loss.
"Boosting women's access to reproductive health care could significantly reduce both the number of unsafe abortions and the high cost of post-abortion medical care in Uganda, experts say," IRIN reports.
› Verified 7 days ago
Dr. Jonathan Hwaien Huang, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2020 Ogden Ave Ste 335, Aurora, IL 60504 Phone: 630-692-5700 | |
Cornelius K Smith, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-859-8700 | |
Dr. Steve B Lowenthal, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4971 | |
Dr. Naveen Divakaruni, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2040 Ogden Ave, Suite 401, Aurora, IL 60504 Phone: 630-585-7100 | |
Dr. Safi Mohammed, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-264-8540 Fax: 630-264-8828 |